19171933_1|19171933|12934|#section_info|1530:1742|Depletion of beta-arrestin-2 not only leads to increases (up to  ~150%) in the induction of cleaved caspase-3 levels by treatment with  hydrogen peroxide or etoposide, but also eliminates AngII-mediated decreases|#main_body|GO:0033033|negative regulation of myeloid cell apoptotic process|Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.|IDA|GOA|Arrb2(25388)|#gene_synonym
19171933_2|19171933|12934|#section_info|1780:2032|On the other hand, knocking-down beta-arrestin-1  leads to decreases in apoptotic reagent-induced caspase-3 cleavage even in the  absence of stimulation with AngII, which is similar in extent to the  protection observed in AngII-treated control cells. |#main_body|GO:0120132|positive regulation of apoptotic process in bone marrow cell|Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.|IGI|GOA|Arrb1(25387)|#gene_synonym
19171933_3|19171933|15232|#section_info|1494:1691|However, unlike control  siRNA-transfected cells, pre-stimulation with AngII fails to reverse the  hydrogen peroxide-induced mitochondrial fragmentation in beta-arrestin-2  siRNA-transfected cells |#main_body|GO:0090201|negative regulation of release of cytochrome c from mitochondria|Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.|IEP|GOA|Arrb2(25388)|#gene_synonym
19171933_4|19171933|17079|#section_info|442:585|On the contrary, we did not observe decreases in DNA  fragmentation after prestimulation with AngII in beta-arrestin-2  siRNA-transfected cells|#main_body|GO:0006309|apoptotic DNA fragmentation|#go_definition|IEP|GOA|Arrb2(25388)|#gene_synonym
19171933_5|19171933|17079|#section_info|667:797|In the case of beta-arrestin-1 knock-down, effects on DNA  fragmentation also mirror the effects observed with caspase-3 cleavage |#main_body|GO:0006309|apoptotic DNA fragmentation|#go_definition|IEP|GOA|Arrb1(25387)|#gene_synonym
19171933_6|19171933|20791|#section_info|505:683|Here we demonstrate that in VSMCs stimulated with AngII, ERK1/2 are activated,  and this is significantly reduced by siRNA-mediated knock-down of  beta-arrestin-2 (Fig. 2,  A-C).|#main_body|GO:0070373|negative regulation of ERK1 and ERK2 cascade|Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.|IDA|GOA|Arrb2(25388)|#gene_synonym
19171933_7|19171933|20791|#section_info|1829:1993$$2078:2188|In control siRNA-transfected cells, p90RSK phosphorylation  also reaches a maximal level at 5 min after stimulation although it lags  slightly behind ERK activation Silencing beta-arrestin-2 expression  leads to rapid and transient p90RSK phosphorylation, also similar to ERK|#main_body|GO:0060394|negative regulation of pathway-restricted SMAD protein phosphorylation|Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.|IDA|GOA|Arrb2(25388)|#gene_synonym
19171933_8|19171933|23332|#section_info|355:495|In these cells, beta-arrestin-2  RNA interference interestingly leads to almost complete attenuation in  AT1R-mediated BAD phosphorylation  |#main_body|GO:0039613|suppression by virus of host protein phosphorylation|Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.|IGI|GOA|Arrb2(25388)|#gene_synonym
19171933_9|19171933|24568|#section_info|326:670|Accordingly, we tested the  ability of AngII to promote phosphorylation of the stimulatory site,  Ser473, of AKT in the VSMCs. As shown in  Fig. 2, J and  K, time-dependent phosphorylation was observed, which was  inhibited by beta-arrestin-2 siRNAs at times later than 2 min of  stimulation, indicating that this process is mediated in part by|#main_body|GO:0051898|negative regulation of protein kinase B signaling|Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.|IEP|GOA|Arrb2(25388)|#gene_synonym
19171933_1|19171933|27312|#section_info|345:415|decreases in these levels in cells  overexpressing the wild-type BAD, |#main_body|GO:1904746|negative regulation of apoptotic process involved in development|Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.|IPI|GOA|Arrb2(25388)|#gene_synonym
19171933_10|19171933|33204|#section_info|215:433|Our results demonstrate  that BAD phosphorylation by RSK is mediated predominantly by  beta-arrestin-2-dependent signaling (Figs.  2G and  4E) and also suggest  that its phosphorylation by AKT is partially dependent on|#main_body|GO:0051898|negative regulation of protein kinase B signaling cascade|Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.|IPI|GOA|Arrb1(25387)|#gene_synonym
19171933_11|19171933|44370|#section_info|0:145|Our data show that knocking-down beta-arrestin-2 expression leads to  almost complete inhibition in RSK-mediated phosphorylation of BAD following|#main_body|GO:0060394|negative regulation of pathway-restricted SMAD protein phosphorylation|Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.|IPI|GOA|Arrb2(25388)|#gene_synonym
